Table 3.
Risk of engraftment syndrome
| Modified Spitzer ES | Modified Maiolino ES | |||||
|---|---|---|---|---|---|---|
| ES, n = 15 | No ES, n = 15 | P-value | ES, n = 17 | No ES, n = 13 | P-value | |
| Splenomegaly, n = 14 | 10/15 | 4/15 | 0.03 | 11/17 | 3/13 | 0.02 |
| Lymphadenopathy, n = 9 | 8/15 | 1/15 | 0.005 | 9/17 | 0/13 | 0.002 |
| Any CTX, n = 8 | 2/15 | 6/15 | NS | 2/17 | 6/13 | 0.03 |
| Mobilization CTX/G, n = 5 | 0/15 | 5/15 | 0.01 | 0/17 | 5/13 | 0.005 |
Any CTX, cyclophosphamide used as therapy or for mobilization.